期刊文献+

微小RNAlet-7c慢病毒载体的构建及过表达研究 被引量:1

Construction of microRNA let-7c lentiviral vector and its overexpression
原文传递
导出
摘要 目的构建微小RNAlet-7c重组慢病毒载体,验证转染该载体系统后对肝癌细胞增殖的影响。方法构建表达含494bplet-7c基因的重组慢病毒载体,检测let-7c及对照组病毒滴度分别为5.01×10E8TU/ml、5.15×10E8TU/ml;转染HepG2细胞,以荧光定量聚合酶链反应(PCR)对let-7c表达水平进行检测;细胞计数试剂盒(CCK-8)试验评价let-7c过表达后对HepG2细胞增殖的影响。结果构建的let-7c慢病毒载体经质粒酶切和测序鉴定正确;转染HepG2细胞72h后,let-Tc表达上调312倍;CCK-8法检测显示HepG2细胞增殖受到明显抑制(P〈0.01)。结论成功构建let-7c重组慢病毒载体并感染HepG2细胞后高效表达成熟let-7c,抑制了HepG2肝癌细胞的增殖。 Objective To construct recombinant lentiviral vector of miRNA let-7c and verify its effect on liver cancer cell proliferation. Methods Recombinant lentiviral vector containing 494 bp let-7c gene was constructed. The titers of Let-To and the controls were 5.01 × 10E8 and 5.15×10E8 TU/ml respectively. Let-To lentiviral vector was transfected into HepG2, and the expression of let-7c was detected by using real time polymerase chain reaction (PCR). Cell counting Kit-8 ( CCK-8 ) method was used to testify HepG2 cell proliferation after the vector transfection. Results The successful construction of let-7c lentiviral vector was confirmed by plasmid enzyme digestion and DNA sequencing. Seventy-two h after the vector transfection, the expression of mature let-Tc was increased by about 312 folds, compared to blank vector transfection. The over-expression of let-7c significantly suppressed HepG2 cell proliferation ( P 〈 0. 01 ). Conclusion The let-Tc recombinant lentiviral vector was successfully constructed. After the vector was transfected to HepG2 cells, mature let-7c was effectively expressed and suppressed the HepG2 liver cancer cell proliferation.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第7期1296-1298,F0004,共4页 Chinese Journal of Experimental Surgery
基金 国家863计划资助项目(2008AA022109) 浙江省科技计划资助项目(2009C33157)
关键词 微小RNA let-7c 慢病毒载体 细胞增殖 MicroRNA Let-7c Lentiviral vector Cell proliferation
  • 相关文献

参考文献12

  • 1Stefani G,Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol,2008,9:219-230.
  • 2Yanaihara N,Caplen N,Bowman E,et al. Unique microRNA molecu- lar profiles in lung cancer diagnosis and prognosis. Cancer Ce11,2006, 9:189-198.
  • 3Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression de- regulation in human breast cancer. Cancer Res,2005 ,65 :7065-7070.
  • 4Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of mi- croRNA expression patterns in hepatocellular carcinoma and non-tu- morous tissues. Oneogene ,2006,25:2537-2545.
  • 5Johnson SM,Grosshans H, Shingara J, et al. RAS is regulated by the let-7 MicroRNA family. Ce11,2005,120:635-647.
  • 6Kim HH,Kuwano Y,Srikantan S, et al. ttuR recruits Iet-7/RISC to repress c-Myc expression. Genes Dev,2009,23 : 1743-1748.
  • 7Boyerinas B, Park SM, Hau A, et a]. The role of let-7 in cell differenti- ation and cancer. Endocr Relat Cancer,2010,17 : FI9-F36.
  • 8Shimizu S,Takehara T, Hikita H,et al. The let-7 family of microRNAs inhibits Bel-xL expression and potentiates sorafenib-induced apoptosis in human hepatoeellular carcinoma. J Hepatol,2010 ,52 :698-704.
  • 9孟春晖,李福年,张佃良.c-myc基因慢病毒载体的构建及其意义[J].中华实验外科杂志,2011,28(4):543-546. 被引量:7
  • 10王志明,刘剑鸣,李萃,段朝军,黄云,李新营.人PPFP基因的重组慢病毒载体的构建和表达[J].中华实验外科杂志,2009,26(11):1435-1438. 被引量:6

二级参考文献24

  • 1张东伟,杨维良.甲状腺癌基因治疗的现状及展望[J].中华实验外科杂志,2005,22(2):255-256. 被引量:16
  • 2李跃萍,宋丽萍,邱曙东.慢病毒载体在肿瘤基因治疗中的应用[J].现代肿瘤医学,2006,14(12):1614-1617. 被引量:17
  • 3Reddi HV, McIver B, Grebe SK, et al. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis. Endocrinology,2007,148:932-935.
  • 4Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPARgammal fusion oncogene in human thyroid carcinoma. Science,2000,289:1357-1360.
  • 5Lang BH, Lo CY, Chan WF, et al. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr Relat Cancer,2007,14:29-42.
  • 6Powell JG,Wang XY,Allard BL,et al. The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition. Oncogene, 2004,23:3634-3641.
  • 7Mclver B, Grebe SKG, Eberhardt NL. The PAXS/PPARγ fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma. Current Drug Targets-Immune, Endocrine & Metabolic Disorders, 2004,4:221-234.
  • 8Sahin M, Allard BL, Yates M, et al. PPARgamma staining as a surrogate for PAXS/PPARgamma fusion oncogene expression in follicular neoplasms:clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab,2005,90:463-468.
  • 9Abbas-Terki T, Blanco-Bose W, Deglon N, et al. Lentiviral mediated RNA interference. Hum Gene Ther,2002 ,13 :2197-2201.
  • 10An DS, Xie Y, Mao SH, et al. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther,2003,14:1207- 1212.

共引文献11

同被引文献7

  • 1Cottin V.Interstitial lung disease[J].Eur Respir Rev,2013,22(127):26-32.
  • 2Doyle TJ,Pinto-Plata V,Morse D,et al.The expanding role of biomarkers in the assessment of smoking-related parenchymal lung diseases[J].Chest,2012,142(4):1027-1034.
  • 3Torregrosa Paredes P,Esser J,Admyre C,et al.Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma[J].Allergy ,2012,67 (7):911-919.
  • 4Pandit KV,Corcoran D,Yousef H,et al.Inhibition and role of let-7d in idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2010,182 (2):220-229.
  • 5Vettori S,Gay S,Distler O.Role of microRNAs in fibrosis[J].Open Rheumatol J,2012,6:130-139.
  • 6徐磊,蒋峰,杨欣,笪良山,钱亦淳,王洁,尹荣,许林.非小细胞肺癌组织微小RNA-145表达及其与预后的关系[J].中华实验外科杂志,2014,31(1):177-179. 被引量:10
  • 7特发性肺(间质)纤维化诊断和治疗指南(草案)[J].中华结核和呼吸杂志,2002,25(7):387-389. 被引量:633

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部